Breyanzi approved for certain types of large B-cell lymphoma
Cell-based gene therapy Breyanzi (lisocabtagene maraleucel) has been approved to treat adults with c...
FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma
Today, the U.S. Food and Drug Administration appro...
Researchers discover potential new drug target to treat cutaneous T cell lymphoma
Cutaneous T cell lymphomas (CTCLs) are a group of ...
Scientists identify a possible new treatment for diabetic retinopathy
About one in three diabetic patients develops diab...
New mechanism for dysfunctional insulin release identified
In a new study, researchers at Uppsala University ...
Kidney disease: Senescent cell burden is reduced in humans by senolytic drugs
In a small safety and feasibility clinical trial, ...
Infant with deadly leukemia saved by drug for adult liver cancer: Identifying genetic mutations may unlock cure for challenging malignancies
UCSF Benioff Children’s Hospitals have succe...
